paxilline has been researched along with Intraepithelial Prostatic Neoplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Ahmadie, H; Jagadeeswaran, R; Kasza, KE; Otto, K; Pienta, KJ; Posadas, EM; Rinker-Schaeffer, C; Robinson, VL; Salgia, R; Siddiqui, J; Stadler, WM; Tretiakov, M | 1 |
1 other study(ies) available for paxilline and Intraepithelial Prostatic Neoplasia
Article | Year |
---|---|
FYN is overexpressed in human prostate cancer.
Topics: Adult; Aged; Blotting, Western; Case-Control Studies; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Paxillin; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Proto-Oncogene Proteins c-fyn; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2009 |